WebApr 17, 2014 · Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction characterised by the formation of antiacetylcholine receptor antibodies (anti-AchR abs) that block neuromuscular transmission, resulting in skeletal muscle weakness. ... Excess magnesium. Pharmacol Rev 1978; 29:273–300 [Google Scholar] 19. Swift TR. … WebMay 4, 2024 · abdominal cramps, increased saliva /mucus, decreased pupil size, increased urination, increased sweating or cold sweat, pale skin, watery eyes, warmth or tingly feeling, or rash or itching. Tell your doctor if you …
Dysarthria - Symptoms and causes - Mayo Clinic
WebMay 17, 2024 · Myasthenia gravis Parkinson's disease Stroke Wilson's disease Some medications, such as certain sedatives and seizure drugs, also can cause dysarthria. Complications Because of the communication problems dysarthria causes, complications can include: Social difficulty. WebDec 6, 2024 · Increased secretion of saliva frequently develops due to inflammation, such as teething, dental caries, and oral cavity infections. Pregnancy is another significant cause of hypersecretion, usually related to hyperemesis gravidarum. dale irene gemelli
Myasthenia gravis - Symptoms and causes - Mayo Clinic
WebSometimes the drugs can cause diarrhea, abdominal cramps, and/or excessive saliva. To minimize these side effects, your physician might lower the dose of cholinesterase inhibitors or prescribe atropine, which blocks the ACh receptors on nerve cells. ... Morel, E. et al. Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 ... Webexcessive saliva is weakness or poor coordination of bulbar or facial musculature. This results in ineffective swallowing mechanics, reduced swallowing frequency, poor lip seal and ineffective saliva control, but not excessive production of saliva.1,5,6 Sialorrhoea commonly affects adults with a variety of neurological conditions including: stroke; WebSep 4, 2024 · Cholinergic crisis is a clinical condition that develops as a result of overstimulation of nicotinic and muscarinic receptors at the neuromuscular junctions and synapses. This is usually secondary to the inactivation or inhibition of acetylcholinesterase (AChE), the enzyme responsible for the degradation of acetylcholine (ACh). Excessive … dale isaac regina